CLINICAL_TRIALS
trial_result
· 2022-02-09
Clinical Trial Update: A Dose Ranging Study of the Effect of Ruxolitinib Phosphate Cream When Applied to Participants With Plaque Psoriasis [Phase 2]
Summary
Phase 2 dose-ranging trial evaluating ruxolitinib phosphate cream in plaque psoriasis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Incyte Corporation | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2022-02-09